24 June 2022 - EMA’s CHMP recommended nine medicines for approval at its June 2022 meeting. ...
22 June 2022 - NICE has announced its decision to reject Fampyra – also known as fampridine – for use ...
22 June 2022 - The MSAC Secretariat has published a list of applications scheduled to be considered by the ESC on ...
21 June 2022 - The Department of Health and Social Care has asked NICE to produce guidance on using slow-release ...
21 June 2022 - The Department of Health and Social Care has asked NICE to produce guidance on using tebentafusp ...
20 June 2022 - The EMA has published a draft agenda for this week's CHMP meeting. ...
17 June 2022 - Zeposia (ozanimod) is included in the high-cost protection with limited subsidy from 17 June 2022. ...
17 June 2022 - Givlaari (givosiran) is included in the high-cost protection with limited subsidy to reduce attacks in patients with ...
17 June 2022 - At the invitation of IQWiG, 41 envoys from European HTA organisations and two from the EU ...
17 June 2022 - The aim of this study was to find ways of bridging the gap in opinions concerning health ...
16 June 2022 - NICE has provisionally approved a new treatment for early breast cancer that it says will benefit ...
17 June 2022 - The outcomes from the May 2022 PBAC meeting are now available. ...
17 June 2022 - Consultation on the content of the draft 2022-23 Cost Recovery Implementation Statement (CRIS) for listing medicines ...
10 June 2022 - CADTH is pleased to announce the four successful core network partners of its inaugural post-market drug ...
16 June 2022 - A new treatment that increases the chance of a successful kidney transplant has been recommended by ...